Subject Index 



AMPS, see a-amino-j)-methoxyphenyl- 



methane sulfonic acid 

 Abraxas grossulariara, nuclear polyhedral 



virus and, 381 

 Absorption, antibody, influenza A virus 



and, 258-260 

 N - Acetyl - - diacetylneuraminic acid, 

 bovine submaxillary gland mucoprotein 

 and, 56 

 N-Acetylglucosamine 



bovine submaxillary gland mucoprotein 



and, 57 

 hemagglutination inhibition and, 53 

 N-Acetylneuraminic acid 

 chemical synthesis of, 54-55 

 human erythrocytes, receptor destroy- 

 ing enzyme and, 55-56 

 urine mucoprotein and, 54 

 6-a-D-N-Acetylneuraminyl-N-acetylgalac- 

 tosamine 

 bovine submaxillary gland mucoprotein 



and, 57 

 receptor-destroying enzyme and, 57 

 Achromobacter xerosis, 220, see also Xerosin 

 Adaptation influenza virus 



hamster lung and, 237-240 

 mouse lung and, 237-240 

 new hosts and, 265-267 

 Rous sarcoma virus and, 319-320 

 Adenoviruses, 3 



bacteiiophage and, 13 

 crystalline aggregates and, 5, 9 

 deoxyribonucleic acid and, 12 

 release of, 141, 142 

 tissue culture, 

 HeLa cells and, 5 

 monkey kidney and, 5 

 Adenocarcinoma, frog and, 101-102, 103, 



105 

 Adenosine, nucleolus effect and, 67, 79 

 Adenoviruses, 65, 103, 252, 270 



cytochemistry, 89-90; deoxyribonucleic 



acid and, 90, 91 

 electron microscopy of, 90-91 

 HeLa cells and, 89, 90, 91 

 Adsorption 



allantoic cavity and, 15, 16, 17 



guinea pig leucocytes, receptor-destroy- 

 ing enzyme and, 17 



influenza virus, respiratory cells and, 52 



viral eclipse phase and, 16 

 African horse sickness virus, intracellular 



soluble antigens and, 132 

 Agglutination , see Hemagglutination 

 Aglais urticae, nuclear polyhedral virus 



and, 388 

 Agratis segetum, granulosis virus and, 378 

 Allantoic cavity, viral adsorption and, 15, 



16, 17 

 Amino acids, deficiency, pathologic cells 



and, 71 

 a-Amino-p-methoxyphenylmethanesul- 

 fonic acid 



infection prevention and, 201 



influenza virus release inhibition and, 

 140, 217 

 Antheraea mylilta, cytoplasmic polyhedral 



virus and, 382 

 Antibiotics, psittacosis virus and, 75 

 Antibody 



absorption, influenza A virus and, 258- 

 260 



fluorescent, viral antigens and, 64, 75, 

 78, 82, 83, 87-89, 94, 103, 133, 152 



neutralizing, infection prevention and, 

 199-200 

 Antigen, see also Soluble antigen 



complement-fixing, occurrence in viruses 

 and, 5 



fowl plague virus, properties of, 128-129 



influenza virus, lag period and, 120-122, 

 123 



phenotypic mixtures, enteroviruses and, 

 9 

 Antihemagglutination, specific antibodies, 



influenza viruses and, 34-35 

 Antimycin A, influenza virus and, 219 

 Arboviruses, 3, 8, 10-11, 13, 252 



coexistence and, 237 



hemagglutination and, 22, 40-42 



ribonucleic acid and, 12 



serological groups and, 6 



407 



